BIOMAT Database Logo BIOMAT Database Logo

Pathogenesis of wasting disease after cyclophosphamide treatment of neonatal mice. 1992

G S Bains, and G S Dhake
Molecular Biology & Agriculture Division, Bhabha Atomic Research Centre, Trombay, Bombay, India.

Cyclophosphamide is a potent immunosuppressive agent and is being widely used in organ transplantation. The effects of this anti-rejection drug on lymphoid organs are poorly understood. Newborn Swiss mice injected with various doses of cyclophosphamide suffered from wasting disease at 4 weeks post treatment. The incidence of wasting disease was dose dependent. Haematological picture of the wasting animals revealed leukocytosis of variable degree. Lymphocyte/granulocyte ratio was not inhibited. The cyclophosphamide treatment caused shrinkage of lymphoid organs. Bone marrow showed degeneration of haematopoietic cells. The failure to sustain lymphopoiesis by the potential lymphoid sites following cyclophosphamide treatment and the associated immunological insufficiency resulted in the fatal wasting disease.

UI MeSH Term Description Entries
D007964 Leukocytosis A transient increase in the number of leukocytes in a body fluid. Pleocytosis,Leukocytoses,Pleocytoses
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

G S Bains, and G S Dhake
Pathogenesis of chronic wasting disease in cervidized transgenic mice.
June 2010, The American journal of pathology,
G S Bains, and G S Dhake
Pathogenesis of the wasting syndrome following neonatal thymectomy.
January 1966, Acta microbiologica Academiae Scientiarum Hungaricae,
G S Bains, and G S Dhake
PATHOGENESIS OF THE POST-NEONATAL THYMECTOMY WASTING SYNDROME.
October 1964, Nature,
G S Bains, and G S Dhake
Wasting syndrome in neonatal mice after administration of salivary gland homogenate.
June 1977, Experientia,
G S Bains, and G S Dhake
Estradiol-induced wasting syndrome in neonatal mice.
February 1967, Journal of immunology (Baltimore, Md. : 1950),
G S Bains, and G S Dhake
Protein half-lives in neonatal mice after a toxic dose of cyclophosphamide.
April 1974, Experientia,
G S Bains, and G S Dhake
Wasting disease and tetany following neonatal pinealectomy.
January 1973, Acta medica Academiae Scientiarum Hungaricae,
G S Bains, and G S Dhake
Pseudomonas aeruginosa infection in mice after treatment with cyclophosphamide.
December 1975, Archives of surgery (Chicago, Ill. : 1960),
G S Bains, and G S Dhake
Transient secretory IgA deficiency in mice after cyclophosphamide treatment.
October 1991, Clinical immunology and immunopathology,
G S Bains, and G S Dhake
Progressive murine cytomegalovirus disease after termination of ganciclovir therapy in mice immunosuppressed by cyclophosphamide treatment.
November 1991, The Journal of infectious diseases,
Copied contents to your clipboard!